Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
7,752,222
-
Share change
-
+198,626
-
Total reported value
-
$150,959,467
-
Price per share
-
$19.47
-
Number of holders
-
31
-
Value change
-
+$3,870,734
-
Number of buys
-
14
-
Number of sells
-
7
Institutional Holders of SIERRA ONCOLOGY INC - COM NEW (SRRA) as of Q2 2021
As of 30 Jun 2021,
SIERRA ONCOLOGY INC - COM NEW (SRRA) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,752,222 shares.
The largest 10 holders included
Vivo Capital, LLC, ORBIMED ADVISORS LLC, Rock Springs Capital Management LP, ADAGE CAPITAL PARTNERS GP, L.L.C., Ikarian Capital, LLC, CAXTON CORP, FRAZIER MANAGEMENT LLC, Ghost Tree Capital, LLC, Opaleye Management Inc., and SILVERARC CAPITAL MANAGEMENT, LLC.
This page lists
31
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.